Oxfordbiotherapeutics
A position at Oxford BioTherapeutics for individuals interested in contributing to innovative work in biotechnology and cancer research.
Headquarters
Oxford, England, United Kingdom
Company Size
11-50 employees
Founded
2004
Oxford BioTherapeutics is a biotechnology company focused on developing first‑in‑class oncology therapies. They pioneer targeted approaches including Antibody‑Drug Conjugates (ADCs), immuno‑oncology agents, T‑Cell Engagers (TCEs), and radiopharmaceuticals. The company advances a pipeline driven by translational science and strategic partnerships to accelerate delivery of novel cancer treatments to patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Oxfordbiotherapeutics.
Oxfordbiotherapeutics didn’t post a salary, so this is our estimate from similar listings.
General Application
Cancer Research Institute Inc
PhD Research Internship
deepmirror
General Interest Application - Tubulis Talent Community (m/f/d)
tubulis
General Application- South San Francisco Biocom Network
Lyell Immunopharma
Cancer Pharmacology and Drug Discovery– Tenure Track Faculty (Assistant/Associate)
Rutgers University
Future Opportunities – Join Our Talent Pipeline
AbbVie